HIV-1 subtypes: epidemiology and significance for HIV management.
about
HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesThe Effect of Clade-Specific Sequence Polymorphisms on HIV-1 Protease Activity and Inhibitor Resistance PathwaysAn evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1National prevalence and trends of HIV transmitted drug resistance in MexicoHIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysisMolecular epidemiology of HIV-1 in Panama: origin of non-B subtypes in samples collected from 2007 to 2013HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.Cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different HIV-1 genetic subtypesImpact of Genetic Variations in HIV-1 Tat on LTR-Mediated Transcription via TAR RNA InteractionMolecular and epidemiological characterization of HIV-1 subtypes among Libyan patients.The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications.Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes.Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Patterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication.Developing and evaluating comprehensive HIV infection control strategies: issues and challengesStructural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbsVirologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.HIV-1 Tat C phosphorylates VE-cadherin complex and increases human brain microvascular endothelial cell permeability.Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis.Mechanisms and factors that influence high frequency retroviral recombinationHIV-1 Genetic Diversity and Its Impact on Baseline CD4+T Cells and Viral Loads among Recently Infected Men Who Have Sex with Men in Shanghai, China.Broad-spectrum anti-human immunodeficiency virus (HIV) potential of a peptide HIV type 1 entry inhibitor.Predictors of disease progression in HIV infection: a review.Variable effect of co-infection on the HIV infectivity: within-host dynamics and epidemiological significance.Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding siteDifferentiating founder and chronic HIV envelope sequences.Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of São Paulo, Brazil.Functional signatures of protective antiviral T-cell immunity in human virus infections.Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).HIV-1 drug resistance mutations: an updated framework for the second decade of HAARTClade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.
P2860
Q26799624-1412FA8B-EF69-4CE1-A4D7-0582864DE031Q27663608-6E7CACD9-9EF7-415F-9EB1-777C210BDC9CQ28471994-30F97B84-F2EB-4BDF-9161-5230025908FDQ28477977-41F3DFC1-A853-4773-9B1D-C571A0160EEDQ28480877-109CE9A3-554C-4895-A590-7CEED12387FBQ28538651-1E49466F-98A1-4349-AE70-EF0E52D20CF5Q30381447-DC7C8D96-EAE6-468C-9905-5B00ADFFDBADQ33328489-71E530E5-5F2B-4DEA-B229-10F7EE96DB58Q33587964-8F19A87C-A75A-4151-BAA4-AD307DB7C85EQ33617645-DFC90A73-380E-431F-B491-6AE6B4C655A0Q33681279-982F76B2-11CF-4FDF-84DE-DD32E7176A51Q33683115-A0215E0A-8AA7-4D97-8269-465B7D49B44DQ33786297-34C7D7F0-6BBA-45A8-9257-A75940067B88Q33850909-B9692BD1-EE5A-4B0C-B8EA-D41C4A6FE77FQ33964088-8E562211-A686-4431-94BC-CCDFE64D1EE3Q34034454-4D246456-631C-4C72-BEE2-59F0763FFD3AQ34387337-F05756D3-29A9-4044-9C7A-EC5571327A8EQ34539819-2D21E107-D8EA-465E-A863-BFFBB77390D0Q34923677-7A33F743-0F2D-43D3-BE9A-AC2A9B165AEFQ35042225-92A8C3F3-0D7F-4BE9-AE3C-CC70F190F681Q35194936-D94B0E55-950F-4893-9450-90F67CF485ECQ35206389-B045DD67-7776-44A1-A369-C948E801D924Q35274900-6EEEEBBC-CDE7-45C5-8D15-4853D7312782Q35276750-AD7D0A59-0A88-4D15-BC58-F049D8DF7655Q35677338-24AD5F59-C6C0-410D-9377-E1514D16B04FQ35785010-BCC6750C-EE66-4199-8395-E233DCF277C1Q35834337-8662F7B4-6649-453A-8D79-147FD7E0BAD1Q35914310-7B8064B6-0C8B-4A88-9AB4-4FAC5B2D3AECQ35984276-D0A2F9FD-CCBD-4EFA-91FF-2B781A3E5F09Q36102994-6675BE23-9F42-4601-A40C-62D2CA9FC75CQ36171647-1A00FCA5-1B8E-41DA-B5F3-2DC115D83F67Q36250427-67520ECD-8D78-4749-BECF-7B5DDFD9E536Q36277153-23919760-CDF5-4BB2-8575-137B9518E582Q36436711-7FF9A6FC-CBBC-4A61-AB5A-202E10E3DE9BQ36529008-9102657C-177A-4112-9874-4202C10F6CD1Q36539298-32A841B2-168F-40A9-A4C7-3C36F0A47DFFQ36600351-A65131D3-50B1-481E-975F-5BBBD02EDB3EQ36653838-B3D03DFC-F51D-4B40-8841-55525C9140A7Q36900010-28B6A1FA-FE3E-4921-BB02-2C890DDD05EAQ36940756-2C0ABE93-F24F-4873-9105-B67715416B90
P2860
HIV-1 subtypes: epidemiology and significance for HIV management.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
HIV-1 subtypes: epidemiology and significance for HIV management.
@ast
HIV-1 subtypes: epidemiology and significance for HIV management.
@en
type
label
HIV-1 subtypes: epidemiology and significance for HIV management.
@ast
HIV-1 subtypes: epidemiology and significance for HIV management.
@en
prefLabel
HIV-1 subtypes: epidemiology and significance for HIV management.
@ast
HIV-1 subtypes: epidemiology and significance for HIV management.
@en
P1476
HIV-1 subtypes: epidemiology and significance for HIV management.
@en
P2093
Anna Maria Geretti
P356
10.1097/01.QCO.0000200293.45532.68
P577
2006-02-01T00:00:00Z